Topical delivery of Anti-VEGF drugs to the Ocular Posterior Segment using Cell-Penetrating Peptides
To evaluate the efficacy of anti-VEGF agents for treating choroidal neovascularization (CNV) when delivered topically using novel cell-penetrating peptides (CPPs) compared with delivery by intravitreal (ivit) injection.
